HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GW nano school

This article was originally published in The Rose Sheet

Executive Summary

George Washington University establishes GW Institute for Nanotechnology, announced Nov. 19. Backed by special endowment funding set aside for academic programs "with the potential for a high level of intellectual distinction," institute will facilitate collaborations among engineering, physics, chemistry and biochemistry faculty members. Sixteen professors are involved in initial projects, including developing a system for nanopatterning and scanning tunneling microscopy, studying growth of carbon nanotubes, creating computational mechanical modeling of nanomaterials, researching nanomagnetics and constructing filtration with nanostructure materials, university says. "National laboratories, federal agencies, and private sector corporations all recognize the as-yet untapped potential for discoveries in this emerging field, and we believe that our engineers and scientists will be among those who unlock some of its exciting secrets," says David Dolling, dean of GW's School of Engineering and Applied Science. While nanotechnology holds great promise in areas ranging "from medicine to electronics to improving water quality worldwide," as Dolling notes, it represents novel risks as well; some consumer groups are calling for tighter FDA oversight and greater transparency from companies (1"The Rose Sheet" Nov. 10, 2008, p. 3)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015809

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel